Print Page   |   Sign In   |   Create a Profile
News & Press: Industry News

Clearside Biomedical goes public

Friday, June 3, 2016   (0 Comments)
Posted by: Angela King
Share |

Clearside Biomedical Inc. (NASDAQ: CLSD) went public Thursday in a $50.4 million IPO.

Its IPO of 7.2 million shares at $7 each is less than half of what it originally sought. According to the Wall Street Journal, the company originally planned to sell 4 million shares between $14 and $16 a share.

The Alpharetta, Ga.-based late stage biopharmaceutical company announced in January it would go public.

Clearside develops drug therapies to treat blinding diseases of the eye using a microinjector to reach diseased tissue.

Source. Atlanta Business Chronicles.

more Calendar

Boehringer-Ingelheim Industry Tour

Member Benefits Webinar

Membership Software Powered by YourMembership  ::  Legal